Log In
Print this Print this

RiVax/VeloThrax combination vaccine

  Manage Alerts
Collapse Summary General Information
Company Soligenix Inc.
DescriptionCombination vaccine comprised of RiVax, an aluminum-adjuvanted recombinant ricin A chain vaccine, and VeloThrax, translocation-deficient mutant recombinant protective antigen (rPA) anthrax vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationAnthrax
Indication DetailsPrevent anthrax and ricin intoxication
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today